A Bengaluru therapy centre reported a middle-aged man with alcohol-related foot drop and liver dysfunction showed full recovery in two weeks after an integrative Yoga-based intervention, with improved ...

As you age, you gradually lose muscle mass and gain visceral body fat, a type of fat deep inside your body that surrounds your heart, kidneys and other organs. Now, scientists say the ratio of ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. This document is entitled the Science ...

Pennsylvania lawmakers are pushing to expand insurance coverage for Lyme disease testing as the state grapples with one of the highest rates of the disease in the country. The initiative, led by a ...

The City Council approved legislation Thursday to ramp up testing requirements of building cooling towers for Legionnaires’ Disease, after an outbreak in Harlem over the summer sickened 114 people, ...

Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, ...

India successfully test fired the nuclear-capable Agni-5 missile from the Integrated Test Range in Odisha, validating all operational and technical parameters. 'I administered medicine through cannula ...

Is your body trying to tell you something? TikTok’s latest health hack has users ditching nutrition labels and instead relying on “muscle reactions” to judge which foods are good for them. Fans claim ...

As AI technology and no-code automation tools continue to evolve, manual testing seems to be losing its edge. This perception may or may not align with reality, as multiple factors are impacting ...

You don’t need six figures to own a legit muscle car. The fourth-gen Chevy Camaro Z28 offers a V8, six-speed manual, and rear-wheel drive—all for Corolla money. In an era dominated by EVs and ...

Dyne Therapeutics, Inc. (NASDAQ:DYN) stock is trading lower after the company announced on Tuesday that it had revised the ongoing Registrational Expansion Cohort in the Phase 1/2 ACHIEVE trial for ...